Strong intrahepatic decline of hepatitis D virus RNA and antigen after 24 weeks of treatment with Myrcludex B in combinationwith Tenofovir in chronic HBV/HDV infected patients: Interim results from a multicenter, open-label phase 2b clinical trial
Allweiss, L., Dettmer, C., Volz, T., Giersch, K., Alexandrov, A., Wedemeyer, H., Urban, S., Bockmann, J.-H., Luetgehmann, M., Dandri, M.Volume:
68
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(18)30398-2
Date:
April, 2018
File:
PDF, 53 KB
english, 2018